BCL2 and schistosomiasis: Furthermore, these components were found to target proteins such as PTGS2, TNF, TGFB1, BCL2, TP53, IL10, JUN, MMP2, IL1B and MYC, suggesting their potential as therapeutic targets for schistosomiasis treatment.